Clinical Trials Logo

Clinical Trial Summary

This study is to assess the feasibility of using a Virtual Reality (VR) headset to provide nature-based Attention-Restorative Therapy (ART) as treatment for cognitive impairment in post-treatment cancer survivors. At ART's foundation is the belief that exposure to nature can improve attention by fully engaging a person in a safe and relaxing experience. This intervention uses a VR headset to expose the participant to nature while overcoming some potential barriers of nature-based interventions like access, physical ability, and bad weather. The goal of this study is to understand if people are willing to use the VR headsets to experience nature virtually, if they find it helpful with cancer-related cognitive impairments (CRCI) symptoms and if they are satisfied with using it. Participants will be asked to use self-management materials (weekly home practice logs, Oculus Go™ and online questionnaires) for 6 weeks. Investigators hope to use information from this small feasibility study to study the effectiveness of the intervention in a larger group of cancer survivors and ultimately to help cancer survivors struggling with cognitive impairments.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05030792
Study type Interventional
Source University of Michigan Rogel Cancer Center
Status Not yet recruiting
Phase N/A
Start date September 2021
Completion date September 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04565769 - Cognitive Function in Patients Treated for Metastatic Melanoma With Immune Checkpoint Inhibitors
Recruiting NCT02661308 - Reducing Cancer Side-effects With Systematic Light Exposure N/A
Completed NCT03452436 - Testosterone, Cognition, Ageing, and Cancer
Recruiting NCT04667689 - An Online Cognitive Assessment in Cancer Patients Phase 2